Literature DB >> 29218273

Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancer.

Feng-Ming Spring Kong1, Fred R Hirsch2, Mitchell Machtay3.   

Abstract

Entities:  

Year:  2017        PMID： 29218273      PMCID： PMC5709135          DOI： 10.21037/tlcr.2017.09.11

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  5 in total

Review 1.  Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.

Authors:  Dirk De Ruysscher; Jianyue Jin; Tim Lautenschlaeger; Jin-Xiong She; Zhongxing Liao; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 2.  Blood-based biomarkers in lung cancer: prognosis and treatment decisions.

Authors:  Meng Xu-Welliver; David P Carbone
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 3.  Blood-based tumor biomarkers in lung cancer for detection and treatment.

Authors:  Hirva Mamdani; Shahid Ahmed; Samantha Armstrong; Tony Mok; Shadia I Jalal
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 4.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

5.  Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation.

Authors:  Feng-Ming Spring Kong; Lujun Zhao; Luhua Wang; Yuhchyau Chen; Jie Hu; Xiaolong Fu; Chunxue Bai; Li Wang; Theodore S Lawrence; Mitchell S Anscher; Adam Dicker; Paul Okunieff
Journal:  Transl Lung Cancer Res       Date:  2017-12
  5 in total
  3 in total

1.  Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis.

Authors:  Chimbu Chinniah; Louise Aguarin; Phillip Cheng; Cristina Decesaris; Alicia Cutillo; Abigail T Berman; Melissa Frick; Abigail Doucette; Keith A Cengel; William Levin; Stephen Hahn; Jay F Dorsey; Charles B Simone; Gary D Kao
Journal:  Clin Lung Cancer       Date:  2019-05-04       Impact factor: 4.785

2.  Integration of Deep Learning Radiomics and Counts of Circulating Tumor Cells Improves Prediction of Outcomes of Early Stage NSCLC Patients Treated With Stereotactic Body Radiation Therapy.

Authors:  Zhicheng Jiao; Hongming Li; Ying Xiao; Jay Dorsey; Charles B Simone; Steven Feigenberg; Gary Kao; Yong Fan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-11       Impact factor: 8.013

3.  Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Authors:  Zhicheng Jiao; Hongming Li; Ying Xiao; Charu Aggarwal; Maya Galperin-Aizenberg; Daniel Pryma; Charles B Simone; Steven J Feigenberg; Gary D Kao; Yong Fan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-01-19       Impact factor: 7.038
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.